Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRITICal: Intermittent Preventive Treatment of Malaria in School-age Children
NCT07246525Phase 4Not yet recruiting
- Sponsor
- University of California, San Francisco
- Start
- Sep 2026
- Primary completion
- Sep 2029
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dihydroartemisinin + piperaquine in malaria, sponsored by University of California, San Francisco. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT07246525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07246525.